230 related articles for article (PubMed ID: 24830321)
21. Mechanism of resistance of African trypanosomes to cytotoxic human HDL.
Hager KM; Hajduk SL
Nature; 1997 Feb; 385(6619):823-6. PubMed ID: 9039915
[TBL] [Abstract][Full Text] [Related]
22. Trypanosome resistance to human innate immunity: targeting Achilles' heel.
Stephens NA; Kieft R; Macleod A; Hajduk SL
Trends Parasitol; 2012 Dec; 28(12):539-45. PubMed ID: 23059119
[TBL] [Abstract][Full Text] [Related]
23. Identification of haptoglobin as a natural inhibitor of trypanocidal activity in human serum.
Smith AB; Hajduk SL
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10262-6. PubMed ID: 7479764
[TBL] [Abstract][Full Text] [Related]
24. Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes.
Thomson R; Molina-Portela P; Mott H; Carrington M; Raper J
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19509-14. PubMed ID: 19858474
[TBL] [Abstract][Full Text] [Related]
25. APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness.
Ilboudo H; Berthier D; Camara M; Camara O; Kabore J; Leno M; Keletigui S; Chantal I; Jamonneau V; Belem AM; Cuny G; Bucheton B
Infect Genet Evol; 2012 Oct; 12(7):1519-23. PubMed ID: 22691369
[TBL] [Abstract][Full Text] [Related]
26. The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill.
Vanhollebeke B; Pays E
Mol Microbiol; 2010 May; 76(4):806-14. PubMed ID: 20398209
[TBL] [Abstract][Full Text] [Related]
27. The human trypanolytic factor: a drug shaped naturally.
Vanhamme L
Infect Disord Drug Targets; 2010 Aug; 10(4):266-82. PubMed ID: 20429865
[TBL] [Abstract][Full Text] [Related]
28. Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target.
Steverding D; Sexton DW; Wang X; Gehrke SS; Wagner GK; Caffrey CR
Int J Parasitol; 2012 May; 42(5):481-8. PubMed ID: 22549023
[TBL] [Abstract][Full Text] [Related]
29. Trypanosoma brucei: Inhibition of cathepsin L is sufficient to kill bloodstream forms.
Steverding D; Rushworth SA; Florea BI; Overkleeft HS
Mol Biochem Parasitol; 2020 Jan; 235():111246. PubMed ID: 31743688
[TBL] [Abstract][Full Text] [Related]
30. Adaptation of Trypanosoma rhodesiense to hypohaptoglobinaemic serum requires transcription of the APOL1 resistance gene in a RNA polymerase I locus.
Lecordier L; Uzureau P; Tebabi P; Brauner J; Benghiat FS; Vanhollebeke B; Pays E
Mol Microbiol; 2015 Aug; 97(3):397-407. PubMed ID: 25899052
[TBL] [Abstract][Full Text] [Related]
31. The trypanolytic factor-mechanism, impacts and applications.
Wheeler RJ
Trends Parasitol; 2010 Sep; 26(9):457-64. PubMed ID: 20646962
[TBL] [Abstract][Full Text] [Related]
32. The significance of human serum sensitivity in the context of T.B. rhodesiense sleeping sickness epidemiology and control.
Rickman LR
East Afr Med J; 1992 May; 69(5):272-8. PubMed ID: 1644047
[TBL] [Abstract][Full Text] [Related]
33. Activity of human trypanosome lytic factor in mice.
Barker C; Barbour KW; Berger FG; Hajduk SL
Mol Biochem Parasitol; 2001 Oct; 117(2):129-36. PubMed ID: 11606222
[TBL] [Abstract][Full Text] [Related]
34. Improved trypanocidal activities of cathepsin L inhibitors.
Nkemgu NJ; Grande R; Hansell E; McKerrow JH; Caffrey CR; Steverding D
Int J Antimicrob Agents; 2003 Aug; 22(2):155-9. PubMed ID: 12927956
[TBL] [Abstract][Full Text] [Related]
35. RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model.
Abdulla MH; O'Brien T; Mackey ZB; Sajid M; Grab DJ; McKerrow JH
PLoS Negl Trop Dis; 2008 Sep; 2(9):e298. PubMed ID: 18820745
[TBL] [Abstract][Full Text] [Related]
36. Human and animal Trypanosomes in Côte d'Ivoire form a single breeding population.
Capewell P; Cooper A; Duffy CW; Tait A; Turner CM; Gibson W; Mehlitz D; Macleod A
PLoS One; 2013; 8(7):e67852. PubMed ID: 23844111
[TBL] [Abstract][Full Text] [Related]
37. A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.
Cooper A; Capewell P; Clucas C; Veitch N; Weir W; Thomson R; Raper J; MacLeod A
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004903. PubMed ID: 27494254
[TBL] [Abstract][Full Text] [Related]
38. [Trypanolytic factor of human serum].
Perez-Morga D
Bull Mem Acad R Med Belg; 2006; 161(5):309-15. PubMed ID: 17283903
[TBL] [Abstract][Full Text] [Related]
39. Human innate immunity against African trypanosomes.
Pays E; Vanhollebeke B
Curr Opin Immunol; 2009 Oct; 21(5):493-8. PubMed ID: 19559585
[TBL] [Abstract][Full Text] [Related]
40. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
